Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

$984K USD

Funder	National Institutes of Health
Recipient Organization	Not specified
Country	USA
Start Date	Dec 11, 2024
End Date	Sep 06, 2026
Duration	634 days
Number of Grantees	1
Data Source	Grants.gov
Grant ID	`0430f169-66e0-47ef-8fef-40258a759c8e`

Grant Description

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.